Insulin resistance and compensatory hyperinsulinemia stimulate proliferative pathways via the IGF-1 and insulin receptors [31], promoting cellular growth and inhibiting apoptosis in thyroid follicular cells [38]. The gene discussed is IGF1; the disease is hyperinsulinism.